Douglas Haynes
Family Medicine · Edmond, OKNPI 1710954367
Payments from drug & device makers
Across 288 payments — averaging $13.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$547
- Novo Nordisk$380
- Merck$327
- Pfizer$311
- Boehringer Ingelheim$274
- Lilly USA, LLC$269
- plus $2K from 28 others
What the payments were for
- Food & beverage$3,800100%
- Education$60%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 50 | $547 |
| Novo Nordisk | 28 | $380 |
| Merck | 29 | $327 |
| Pfizer | 24 | $311 |
| Boehringer Ingelheim | 24 | $274 |
| Lilly USA, LLC | 26 | $269 |
| AbbVie | 14 | $260 |
| Sanofi-aventis U.S. LLC | 18 | $225 |
| AstraZeneca | 16 | $218 |
| Abbott | 8 | $150 |
| Amgen | 8 | $128 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 7 | $109 |
| Eisai Inc. | 3 | $62 |
| Ironshore Pharmaceuticals Inc. | 4 | $55 |
| Astellas Pharma US Inc | 3 | $53 |
| Hologic Sales And Service, LLC | 2 | $40 |
| Exact Sciences | 2 | $39 |
| Ultragenyx Pharmaceutical Inc. | 2 | $33 |
| Amarin Pharma, Inc. | 2 | $32 |
| Antares Pharma, Inc. | 2 | $28 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Bayer | 1 | $27 |
| Johnson & Johnson | 2 | $24 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Novartis | 1 | $21 |
| Halozyme Inc | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $20 |
| Dynavax Technologies Corporation | 1 | $18 |
| Sanofi Pasteur Inc. | 1 | $16 |
| Adlon Therapeutics L.p. | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Amneal Pharmaceuticals LLC | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $12 |
How this compares
$3,806 in reported general payments places this provider in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 22 | $25,652 |
| Novolog FlexpenInsulin Aspart | 13 | $2,608 |
| Rosuvastatin Calcium | 58 | $1,069 |
| Atorvastatin Calcium | 40 | $804 |
| SynthroidLevothyroxine Sodium | 12 | $787 |
| Losartan Potassium | 46 | $715 |
| Duloxetine Hcl | 26 | $702 |
| Estradiol | 11 | $641 |
| Gabapentin | 23 | $531 |
| Levothyroxine Sodium | 46 | $496 |
| Sertraline Hcl | 25 | $486 |
| Mirtazapine | 15 | $484 |
| Amlodipine Besylate | 53 | $471 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 13 | $412 |
| Potassium Chloride | 19 | $368 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $269 | $25,65222 claims |
| AbbVieSynthroid | $260 | $78712 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $13 | $49646 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,730 family medicine providers in Oklahoma.
Other family medicine in Edmond
- Stanley ShadidEdmond$363K
- Susan DimickEdmond$256K
- Charles WoodwardEdmond$15K
- Carl GriffinOklahoma City$28.2M
- Lisa ConneryNorman$15.6M
- Kyle RicknerYukon$14.7M
- Robert LockwoodYukon$8.6M
- Steven CoxNorman$6.9M
- Alexander FrankOklahoma City$3.1M
- Rachel AndersonNorman$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.